Indole conjugated silica and magnetic nanoparticles as inhibitors of HIF

Colloids and Surfaces B: Biointerfaces

Volumn 114, Issue , 2014, Pages 158-163

  Chen, Qiu Yun ^a,b   Wang, Zhi Wei ^a   Yang, Xia ^a   Wang, Li ^a,b  

^a JIANGSU UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Glycolysis; HIF; Indole; Magnetic nanoparticle; Silica

Indexed keywords

CHLORINE COMPOUNDS; FUNCTIONAL GROUPS; ORGANIC POLYMERS; POLYCYCLIC AROMATIC HYDROCARBONS; SILICA;

AMINE GROUPS; GLUCOSE TRANSPORTERS; GLYCOLYSIS; HIF; HYPOXIA-INDUCIBLE FACTORS; INDOLE; MAGNETIC NANO-PARTICLES; SCHIFF BASIS;

NANOPARTICLES;

3 INDOLECARBALDEHYDE; 4 ACETYL N ALLYL PYRIDINIUM CHLORIDE; ALDEHYDE; CATALASE; FERRIC OXIDE; GLUCOSE TRANSPORTER; HYDROGEN PEROXIDE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INDOLE DERIVATIVE; LACTIC ACID; MAGNETIC NANOPARTICLE; OXYGEN; PYRIDINIUM DERIVATIVE; SCHIFF BASE; SILICON DIOXIDE; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CELL STRAIN HEPG2; CELL VIABILITY; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; PERIODIC ACID SCHIFF STAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNTHESIS;

GLYCOLYSIS; HIF; INDOLE; MAGNETIC NANOPARTICLE; SILICA;

CATALASE; CELL DEATH; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSE TRANSPORTER TYPE 1; HEP G2 CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INDOLES; KINETICS; LACTIC ACID; MAGNETITE NANOPARTICLES; OXYGEN; RNA, MESSENGER; SILICON DIOXIDE; SPECTROPHOTOMETRY, INFRARED; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 84886838330     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2013.10.004     Document Type: Article

References (19)

1. Semenza G.L. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol. Sci. 2012, 33:207-214.
2. López-Lázaro M. The Warburg effect: why and how do cancer cells activate glycolysis in the presence of oxygen?. Anti-Cancer Agents Med. Chem. 2009, 9:517-525.
3. God N., Kanai N.M. Hypoxia-inducible factors and their roles in energy metabolism. Int. J. Hematol. 2012, 95:457-463.
4. Mucaj V., Sha J.E.S., Simon M.C. Effects of hypoxia and HIFs on cancer metabolism. Int. J. Hematol. 2012, 95:464-470.
5. Pelicano H., Martin D.S., Xu R.H. Glycolysis inhibition for anticancer treatment. Oncogene 2006, 25:4633-4646.
6. Scheuermann T.H., Li Q.M., Ma H.W., Key J., Zhang L., Chen R., Garcia J.A., Naidoo J., Frantz D.E., Tambar U.K., Gardner K.H., Bruick R.K. Allosteric inhibition of hypoxia inducible factor-2 with small molecules. Nat. Chem. Biol. 2013, 9:271-276.
7. Vogelstein B., Kinzler K.W. Cancer genes and the pathways they control. Nat. Med. 2004, 10:789-799.
8. Gogvadze V., Zhivotovsky B., Orrenius S. The Warburg effect and mitochondrial stability in cancer cells. Mol. Aspects Med. 2010, 31:60-74.
9. Heiden M.G.V. Targeting cancer metabolism: a therapeutic window opens. Nat. Rev. Drug Discov. 2011, 10:672-684.
10. Sinha D., Tiwari A.K., Singh S., Shukla G., Mishra P., Chandra H., Mishra A.K. Synthesis, characterization and biological activity of Schiff base analogues of indole-3-carboxaldehyde. Eur. J. Med. Chem. 2008, 43:160-165.
11. Rosu T., Pahontu E., Ilies D.C., Georgescu R., Mocanu M., Leabu M., Shova S., Gulea A. Synthesis and characterization of some new complexes of Cu(II), Ni(II) and V(IV) with Schiff base derived from indole-3-carboxaldehyde. Biological activity on prokaryotes and eukaryotes. Eur. J. Med. Chem. 2012, 53:380-389.
12. Ward R.A., Brassington C., Breeze A.L., Caputo A., Critchlow S., Davies G., Goodwin L., Hassall G., Greenwood R., Holdgate G.A., Mrosek M., Norman R.A., Pearson S., Tart J., Tucker J.A., Vogtherr M., Whittaker D., Wingfield J., Winter J., Hudson K. Design and synthesis of novel lactate dehydrogenase A inhibitors by fragment-based lead generation. J. Med. Chem. 2012, 55:3285-3306.
13. Tao Z.M., Toms B., Goodisman J., Asefa T. Mesoporous silica microparticles enhance the cytotoxicity of anticancer platinum drugs. ACS Nano 2010, 4:789-794.
14. Xie M., Shi H., Li Z., Shen H.J., Ma K., Li B., Shen S., Jin Y. A multifunctional mesoporous silica nanocomposite for targeted delivery, controlled release of doxorubicin and bioimaging. Colloids Surf. B: Biointerface 2013, 110:138-147.
15. Miao J., Du Y.Z., Yuan H., Zhang X.G., Hu F.Q. Drug resistance reversal activity of anticancer drug loaded solid lipid nanoparticles in multi-drug resistant cancer cells. Colloids Surf. B: Biointerface 2013, 110:74-80.
16. Yang X., Chen Q.Y., Kong M.Y., Qu L.L., Geng Z.R., Wang Z.L. An ionic liquid-modified nano-vehicle to construct nano-models of catalase to target mitochondria. J. Mater. Chem. 2012, 22:20304-22209.
17. Chen Q.Y., Tao G.P., Liu Y.Q., Yang X. Synthesis, characterization, cell imaging and anti-tumor activity of multifunctional nanoparticles. Spectrochim. Acta Part A: Mol. Biomol. Spectrosc. 2012, 96:284-288.
18. Dehne N., Hintereder G., Brüne B. High glucose concentrations attenuate hypoxia-inducible factor-1α expression and signaling in non-tumor cells. Exp. Cell Res. 2010, 316:1179-1189.
19. Chen J.Q., Russo J. Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells. Biochem. Biophys. Acta 2012, 1826:370-384.